DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Cryoprecipitate is an investigational drug.
There have been 22 clinical trials for Cryoprecipitate. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2008.
The most common disease conditions in clinical trials are Blood Coagulation Disorders, Hemostatic Disorders, and Hemorrhage. The leading clinical trial sponsors are CSL Behring, Australian Red Cross, and Gold Coast Hospital and Health Service.
Recent Clinical Trials for Cryoprecipitate
|A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)||Lee's Pharmaceutical Limited||Phase 2|
|In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)||Emory University||Phase 3|
|Fibrinogen Concentrate In Children Cardiac Surgery 2||Filomena R B G Galas||Phase 4|